135 related articles for article (PubMed ID: 31881052)
1. Clarithromycin use and the risk of mortality and cardiovascular events: A systematic review and meta-analysis.
You CH; Lin CK; Chen PH; Park S; Chen YY; Khan N; Papatheodorou SI; Chen ST
PLoS One; 2019; 14(12):e0226637. PubMed ID: 31881052
[TBL] [Abstract][Full Text] [Related]
2. Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis.
Wong AYS; Chan EW; Anand S; Worsley AJ; Wong ICK
Drug Saf; 2017 Aug; 40(8):663-677. PubMed ID: 28397186
[TBL] [Abstract][Full Text] [Related]
3. Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides.
Gorelik E; Masarwa R; Perlman A; Rotshild V; Muszkat M; Matok I
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610207
[TBL] [Abstract][Full Text] [Related]
4. Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study.
Berni E; de Voogd H; Halcox JP; Butler CC; Bannister CA; Jenkins-Jones S; Jones B; Ouwens M; Currie CJ
BMJ Open; 2017 Jan; 7(1):e013398. PubMed ID: 28115334
[TBL] [Abstract][Full Text] [Related]
5. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
[TBL] [Abstract][Full Text] [Related]
6. Estimated Cardiac Risk Associated With Macrolides and Fluoroquinolones Decreases Substantially When Adjusting for Patient Characteristics and Comorbidities.
Polgreen LA; Riedle BN; Cavanaugh JE; Girotra S; London B; Schroeder MC; Polgreen PM
J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29680825
[TBL] [Abstract][Full Text] [Related]
7. Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
Chou HW; Wang JL; Chang CH; Lai CL; Lai MS; Chan KA
Clin Infect Dis; 2015 Feb; 60(4):566-77. PubMed ID: 25409476
[TBL] [Abstract][Full Text] [Related]
8. Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials.
Seidu S; Achana FA; Gray LJ; Davies MJ; Khunti K
Diabet Med; 2016 Mar; 33(3):280-9. PubMed ID: 26282461
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis.
Alexander GC; Iyer G; Lucas E; Lin D; Singh S
Am J Med; 2017 Mar; 130(3):293-305. PubMed ID: 27751897
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs.
Root AA; Wong AY; Ghebremichael-Weldeselassie Y; Smeeth L; Bhaskaran K; Evans SJ; Brauer R; Wong IC; Navaratnam V; Douglas I
Br J Clin Pharmacol; 2016 Aug; 82(2):512-21. PubMed ID: 27090996
[TBL] [Abstract][Full Text] [Related]
11. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
[TBL] [Abstract][Full Text] [Related]
12. Impact of Aldosterone Antagonists on Sudden Cardiac Death Prevention in Heart Failure and Post-Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Le HH; El-Khatib C; Mombled M; Guitarian F; Al-Gobari M; Fall M; Janiaud P; Marchant I; Cucherat M; Bejan-Angoulvant T; Gueyffier F
PLoS One; 2016; 11(2):e0145958. PubMed ID: 26891235
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive use and cardiovascular disease: is the relationship real or due to study bias?
Katerndahl DA; Realini JP; Cohen PA
J Fam Pract; 1992 Aug; 35(2):147-57. PubMed ID: 1386621
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies.
Schembri S; Williamson PA; Short PM; Singanayagam A; Akram A; Taylor J; Singanayagam A; Hill AT; Chalmers JD
BMJ; 2013 Mar; 346():f1235. PubMed ID: 23525864
[TBL] [Abstract][Full Text] [Related]
15. Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis.
Brunström M; Carlberg B
JAMA Intern Med; 2018 Jan; 178(1):28-36. PubMed ID: 29131895
[TBL] [Abstract][Full Text] [Related]
16. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
